Bogorad's syndrome

Bogorad's Syndrome also known as Crocodile Tears Syndrome is a rare medical condition characterized by the overproduction of tears during salivation while the patient is eating or thinking about food. It is named after the Russian neurologist Friedrich Bogorad, who first described the condition in 1926.

Etiology

Bogorad's Syndrome is usually a complication of Bell's palsy, a condition that causes temporary weakness or paralysis of the muscles in the face. It can also occur as a result of other conditions that cause facial nerve damage, such as neurosurgery, infections, tumors, or trauma. The syndrome is caused by the misdirection of regenerating nerve fibers, which results in the simultaneous stimulation of the lacrimal and salivary glands.

Symptoms

The primary symptom of Bogorad's Syndrome is the overproduction of tears during salivation. This can occur when the patient is eating, thinking about food, or even talking about food. Other symptoms can include dry mouth, facial weakness, and difficulty swallowing.

Diagnosis

Diagnosis of Bogorad's Syndrome is primarily based on the patient's symptoms and medical history. Additional tests, such as MRI or CT scan, may be used to rule out other conditions that can cause similar symptoms.

Treatment

Treatment for Bogorad's Syndrome primarily involves managing the symptoms. This can include using artificial tears to help keep the eyes moist, and medications to reduce the production of saliva. In severe cases, surgical intervention may be necessary.

Prognosis

The prognosis for Bogorad's Syndrome varies depending on the underlying cause. In cases where the syndrome is caused by Bell's palsy, most patients will see an improvement in their symptoms within three to six months. However, in cases where the syndrome is caused by other conditions, such as tumors or trauma, the prognosis may be less favorable.

See also

• Bell's palsy
• Facial nerve paralysis
• Lacrimation

‎

Resources

Latest articles - Bogorad's syndrome

• Most recent articles
• Ongoing trials

‎ Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Bogorad's syndrome for any updates.

‎